Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-04

Clinical Trial Update: Intrathecal Pemetrexed for Leptomeningeal Metastasis [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating intrathecal pemetrexed for leptomeningeal metastasis has completed. The study was sponsored by The First Hospital of Jilin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pemetrexed (pemetrexed)

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: Leptomeningeal Metastases | Phase 1, Phase 2 | Status: COMPLETED